“…Additionally, AI/ML introduced new approaches in computer-aided detection, assisted interpretation, computer-aided diagnosis [ 13 , 17 , 19 ], as well as for reducing administered dose and radiation exposure to the patient [ 15 ]. From the clinical perspective, AI/ML applications span the entire spectrum of nuclear medicine, with the three main areas being: cardiology for myocardial perfusion imaging and detection of coronary artery disease or prediction of major adverse cardiac events [ 16 , 20 ]; neurology for neurodegenerative diseases such as Alzheimer’s, Parkinson’s, and other dementia [ 16 , 21 , 22 ]; and oncology, where it significantly impacted lesion detection and tracking, radiopharmaceutical therapies with precision dosimetry, personalized treatment planning, and therapy response assessment [ 12 , 16 , 19 , 23 ]. AI/ML applications explored new venues in drug discovery, radiopharmacy, and radiochemistry [ 24 ], that greatly enhanced the evolving field of theranostics [ 12 , 23 , 25 ].…”